Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Feb;20(2):216-22.
doi: 10.1007/s00167-011-1630-x. Epub 2011 Aug 31.

Expression of β-defensin-4 in "an in vivo and ex vivo model" of human osteoarthritic knee meniscus

Affiliations

Expression of β-defensin-4 in "an in vivo and ex vivo model" of human osteoarthritic knee meniscus

Giuseppe Musumeci et al. Knee Surg Sports Traumatol Arthrosc. 2012 Feb.

Abstract

Purpose: To investigate, for the first time, the expression of β-defensins-4, by immunohistochemistry and western blotting, in OA meniscus versus control meniscus, thus providing new insights into the physiological processes of meniscus repairing.

Method: β-defensins-4 was studied in vivo, in knee osteoarthritic menisci obtained from 30 patients (20 men and 10 women) who underwent isolated arthroscopic partial medial or lateral meniscectomy, and in vitro on fibrochondrocyte cells from human OA knee menisci. The study was conducted using morphological, immunohistochemical, and Western blot analysis.

Results: The histological results demonstrated structural alterations and cracks of OA menisci accompanied by a very strong β-defensin-4 immunohistochemical staining. The Western blot analysis confirmed also a strong expression of β-defensin-4 in OA fibrochondrocyte cells.

Conclusion: The present study suggests an activation of β-defensin-4 induction, in human knee meniscus induced by the OA inflammatory process. It may represent an endogenous antibiotic defense mechanism accompanied by an intrinsic effort of tissue remodeling in OA articular joints. In conclusion, the present paper suggests the clinical relevance of β-defensin-4 in the prospective of future alternative medical treatment for OA.

PubMed Disclaimer

References

    1. Am J Respir Cell Mol Biol. 2000 Jun;22(6):714-21 - PubMed
    1. Nature. 1997 Jun 26;387(6636):861 - PubMed
    1. Arthritis Rheum. 2006 Aug;54(8):2488-95 - PubMed
    1. Arthritis Rheum. 2004 Nov;50(11):3526-34 - PubMed
    1. Histol Histopathol. 2009 Mar;24(3):293-8 - PubMed

Publication types

LinkOut - more resources